Latest Market Growth News

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

Lark Distilling Co. has reported its sixth consecutive quarter of sales growth, with net sales rising 11% to $5 million in Q2 FY26, as it prepares to launch a refreshed brand portfolio domestically and internationally.

Strategic Elements Ltd’s subsidiary Stealth Technologies has secured its inaugural commercial pilot deployment of the EdgeiQ system at an underground gold mine in Western Australia, marking a significant milestone in the technology’s commercialisation journey.

XRF Scientific is set to open a new office in India, shifting from a distributor model to direct presence to capture growing demand in mining and industrial sectors. This move aims to strengthen sales and customer trust in one of the world’s fastest-growing economies.

Adveritas Limited has reported a record $14.25 million annualised recurring revenue for the December 2025 quarter, driven by strong US market growth and AI-enhanced product development. The company’s strategic focus on media agency partnerships and new product lines signals robust momentum ahead.

Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.

Vitrafy Life Sciences has entered a 12-month exclusive partnership with IMV Technologies to integrate cryopreservation technologies, securing up to A$930k in fees and milestone payments.

CurveBeam AI has received official Chinese regulatory approval for a strategic $10 million investment from WEGO Orthopaedics, marking a major step in its expansion into Greater China. The initial $4 million tranche at a premium share price is expected imminently, underpinning a decade-long commercialisation deal.

Acrux Limited has sold the US registration and distribution rights for its Prilocaine 2.5% and Lidocaine 2.5% cream for US$550,000, redirecting resources towards its growing Hormone Replacement Therapy portfolio.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Ava Risk Group’s BQT Solutions has inked a five-year supply and co-development agreement with US-based UniKey Technologies, targeting the booming mobile credential access market with new NFC/BLE readers.